Cortical Labs develops biological computing systems that integrate lab-grown neurons with silicon chips in closed-loop architectures, enabling real-time interaction between living neuronal tissue and software. The company deploys this capability through two interfaces: the CL1, a code-deployable device for direct on-premise experimentation, and the Cortical Cloud, a remote access platform. Both target researchers and developers seeking to run experiments on actual neurons rather than relying exclusively on digital simulation.
The core technical problem the platform addresses is accessibility to functional neuronal systems for empirical work. The CL1 integrates cultivated neurons with real-time closed-loop control, allowing neurons to process information and adapt within software-defined environments. The Cortical Cloud extends this capability through remote deployment, trading deployment latency and network overhead for operational simplification and shared infrastructure economics. The system trades traditional compute power consumption against the metabolic efficiency characteristics of biological processing, though scaling behavior under realistic workloads remains an open question in the field.
Positioned as an animal-free alternative for laboratory testing, the platform targets neuroscience research, medical laboratories, and biotechnology workflows where direct neuronal observation and interaction currently require either in vivo work or computationally expensive digital models. The stated intent is to accelerate insights supporting human health outcomes by removing friction between hypothesis and neuronal-level validation.